For treating the receptor antagonists of NK 3 of processing or cosmetic treatments excess body fat
CA2929436A1
Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
CA2907814A1
Novel n-acyl-(3-substituted)-(8-methyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective nk-3 receptor antagonists, pharmaceutical composition, methods for use in nk-3 receptor-mediated disorders
CA2907809A1
N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective nk-3 receptor antagonists, pharmaceutical composition, methods for use in nk-3 receptor-mediated disorders
US2014275097A1
Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof
WO2011151434A1
Novel compounds, pharmaceutical composition and methods for use in treating metabolic disorders
WO2011151436A2
Azepin-derivatives as derivatives as g- protein coupled receptor (gpr43) agonists
WO2011092284A1
Novel amino acid derivatives and their use as gpr43 receptor modulators
WO2011076734A1
Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
WO2011076732A1
Compounds, pharmaceutical composition and methods for use in treating gastrointestinal disorders
CN102245574A
Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
WO2009010479A2
Heterocyclic methylene piperidine derivatives and their use
WO2009010480A1
1-{2-[(diphenyl)amino]-ethyl}-piperidine-4-carboxylic acid benzylamide derivatives and related compounds as ccr5 agonists for the treatment of immune and inflammatory diseases
EP2164491A1
Piperidine-4-acetic acid derivatives and their use
WO2009010478A2
Use of piperidine derivatives as agonists of chemokine receptor activity
EP1867994A2
Ligand for G-protein coupled receptor GPR72 and uses thereof
CA2589393A1
Ligand for g-protein coupled receptor gpr72 and uses thereof
US2007213510A1
Compositions and methods comprising a ligand of ChemerinR
US2007213508A1
Antibody that specifically binds to Chemerin receptor ligand precursor
CA2810292A1
Ligand for g-protein coupled receptor fprl2 and uses thereof
